For the years ended December 31, 2025 and 2024, the following warrants, contingent earnout shares, performance based management earnout
shares, were excluded from the computation of diluted net loss per common share, as the inclusion would have been anti-dilutive.
Schedule of Anti-dilutive Shares
| | |
2025 | | |
2024 | |
| Anti-dilutive shares excluded from net loss per share | |
| | | |
| | |
| Warrants Outstanding | |
| 14,107,989 | | |
| 14,107,989 | |
| Contingent Earnout Shares | |
| 26,000,000 | | |
| 26,000,000 | |
| Performance Based Management Earnout | |
| - | | |
| 2,000,000 | |
| Total Anti-dilutive shares excluded from net loss per share | |
| 40,107,989 | | |
| 42,107,989 | |
|